Clinical trial
Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression…
NCT00130910 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00130910 |
|---|---|
| Title | Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation |
| Official title | Randomized, Double Blind, Placebo Controlled Trial of Albendazole in Soil-Transmitted Helminth and HIV-1 co-Infected Kenyan Individuals to Determine the Effect of Such Treatment on HIV-1 Disease Progression and Genital Shedding. |
| Lead sponsor | University of Washington, Other |
| Collaborators | Kenya Medical Research Institute University of Nairobi Kenyatta National Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Helminthiasis |
| Intervention type | Drug |
| Interventions | Albendazole, Placebo |
| Enrollment | 234 |
| Start date | Mar 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Aug 16, 2005 |
| Last update posted | Nov 15, 2007 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: